同济大学学报(医学版)2024,Vol.45Issue(1) :145-151.DOI:10.12289/j.issn.1008-0392.23109

慢性硬膜下血肿的发病机制和治疗研究进展

Recent advances in pathogenesis and treatments of chronic subdural hematoma

杨浚宇 魏亮
同济大学学报(医学版)2024,Vol.45Issue(1) :145-151.DOI:10.12289/j.issn.1008-0392.23109

慢性硬膜下血肿的发病机制和治疗研究进展

Recent advances in pathogenesis and treatments of chronic subdural hematoma

杨浚宇 1魏亮1
扫码查看

作者信息

  • 1. 同济大学附属东方医院神经外科,上海 200120
  • 折叠

摘要

慢性硬膜下血肿是最常见的神经外科疾病之一,尤其在老年人群中,其发病率呈逐年上升趋势.该疾病在得到充分治疗后仍有一定的复发率、发病率、死亡率.过去几十年中,对慢性硬膜下血肿病理生理学的新认知、手术或非手术的新疗法成为研究重点.本文对慢性硬膜下血肿的流行病学及危险因素、病理生理学、手术治疗及非手术治疗、术后复发危险因素及疾病复发预防进行综述,旨在了解慢性硬膜下血肿临床管理现状,并且提出未来可能的研究重点.

Abstract

Chronic subdural hematoma(CSDH)is one of the most common neurological disorders with continuously increasing incidence,especially among elderly individuals.The disease has certain recurrence rate,complication rate and death rate,even in patients with adequate treatment.With the new insight for the pathophysiological mechanisms of CSDH,new treatment modalities,surgical and non-surgical,have become research focus in the past decades.This article reviews the recent advances in CSDH research,focus on epidemiology and risk factors,pathophysiology,surgical and non-surgical treatments,risk and prevention of recurrence,to provide reference for clinical management and further research of CSDH.

关键词

慢性硬膜下血肿/病理生理学/临床治疗/硬膜下血肿

Key words

chronic subdural hematoma/pathophysiology/clinical therapy/subdural hematoma

引用本文复制引用

基金项目

上海市浦东新区科技发展基金事业单位民生科研专项医疗卫生项目(PKJ2022-Y55)

出版年

2024
同济大学学报(医学版)
同济大学

同济大学学报(医学版)

CSTPCD
影响因子:0.51
ISSN:1008-0392
参考文献量52
段落导航相关论文